Imricor Medical Systems Inc (ASX:IMR)
A$ 0.49 -0.03 (-5.77%) Market Cap: 123.67 Mil Enterprise Value: 137.83 Mil PE Ratio: 0 PB Ratio: 0 GF Score: 18/100

Half Year 2021 Imricor Medical Systems Inc Earnings Call Transcript

Aug 25, 2021 / 11:00PM GMT
Release Date Price: A$1.19 (-1.99%)
Operator

Thank you for standing by, and welcome to the Imricor Medical HY '21 Results Briefing Conference Call. (Operator Instructions)

I would now like to hand over the conference to Mr. Steve Wedan, Chair and CEO. Thank you. Please go ahead.

Steve Wedan
Imricor Medical Systems, Inc. - CEO, President & Executive Chairman

Hello, everyone, and thank you for joining us today for Imricor's first half results. I'm Steve Wedan, Imricor's Chair and CEO. And I'm joined today by our CFO, Lori Milbrandt. Today, we'll provide you with a business update on the progress we have made during the first half of 2021, including a review of key milestones that we've achieved since our IPO, and the progress we've made on our overall strategy. Lori will then discuss the financial results for the first half before I review our market opportunity and the outlook for the remainder of the year. We'll then move to a Q&A session.

So since our IPO in late 2019, Imricor has delivered strong outcomes on a significant number of key initiatives that support our strategic

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot